Patents Assigned to Jaleva Pharmaceuticals, LLC
  • Publication number: 20170296674
    Abstract: Described are pharmacological compositions comprising a gum resin; a pharmacologically active agent and a topically acceptable volatile solvent for the gum resin and active agent. Also described are methods for the transdermal or transmucosal delivery of a pharmacologically active agent using such compositions.
    Type: Application
    Filed: November 4, 2016
    Publication date: October 19, 2017
    Applicant: Jaleva Pharmaceuticals, LLC
    Inventors: Alex Battaglia, Eva Beim
  • Patent number: 9554984
    Abstract: The invention provides a biological dressing for treatment of a condition of the skin, mucosa, teeth or other tissue within or proximate to the oral cavity of a subject, the biological dressing comprised of a gum resin, a topically acceptable volatile solvent, and an oral care agent. The gum resin is present in a suitable amount that the composition, when the solvent evaporates, will dry to form a solid coating that sticks to the tissue to which the composition is applied and maintain the oral care agent over a sustained period of time in contact with sites on the tissue exhibiting symptoms of the condition. Methods are provided for treating symptoms of oral condition with such a oral care composition.
    Type: Grant
    Filed: January 9, 2004
    Date of Patent: January 31, 2017
    Assignee: JALEVA PHARMACEUTICALS, LLC
    Inventors: Alex Battaglia, Eva Beim
  • Publication number: 20150306362
    Abstract: A dual chamber applicator includes an elongated tube having a sealed end and an open end, a first ampoule disposed in the elongated tube and containing a first composition including a pharmaceutically active agent and optionally a first volatile solvent, water, or a combination thereof, a second ampoule disposed in the elongated tube and containing a second composition including a resin based tincture, a second volatile solvent and water, and an applicator device provided at the open end of the elongated tube. The first composition is configured to combine with the second composition within the elongated tube to form a medicine to be delivered to a mucosal site or a skin site. The applicator device is configured to control flow of the medicine out of the open end of the elongated tube and deliver the medicine via topical, transdermal or transmucosal delivery.
    Type: Application
    Filed: November 26, 2013
    Publication date: October 29, 2015
    Applicant: Jaleva Pharmaceuticals, LLC
    Inventor: Alex BATTAGLIA
  • Publication number: 20150051200
    Abstract: Described are pharmacological compositions comprising a gum resin; a pharmacologically active agent and a topically acceptable volatile solvent for the gum resin and active agent. Also described are methods for the transdermal or transmucosal delivery of a pharmacologically active agent using such compositions.
    Type: Application
    Filed: September 5, 2014
    Publication date: February 19, 2015
    Applicant: Jaleva Pharmaceuticals, LLC
    Inventors: Alex Battaglia, Eva Beim
  • Publication number: 20140371210
    Abstract: A method of rapid transbuccal delivery of an active agent into the bloodstream is provided. The method can include providing a pharmaceutical composition comprising the active agent, resin and a volatile solvent and, optionally, water. In some embodiments, the method achieves a Tmax 60 minutes or less, an onset of therapeutic effect of 60 minutes or less, and/or achieves therapeutic serum levels of the active agent within 60 minutes or less. Related compositions also are provided.
    Type: Application
    Filed: October 12, 2012
    Publication date: December 18, 2014
    Applicant: Jaleva Pharmaceuticals, LLC
    Inventor: Alex Battaglia
  • Patent number: 8846092
    Abstract: Described are pharmacological compositions comprising a gum resin; a pharmacologically active agent and a topically acceptable volatile solvent for the gum resin and active agent. Also described are methods for the transdermal or transmucosal delivery of a pharmacologically active agent using such compositions.
    Type: Grant
    Filed: May 4, 2012
    Date of Patent: September 30, 2014
    Assignee: Jaleva Pharmaceuticals, LLC
    Inventors: Alex Battaglia, Eva Beim
  • Patent number: 8709439
    Abstract: The invention provides a biological dressing for treatment of a dermatological disease comprised of one or more resins or other film-forming agents, a topically acceptable volatile solvent, and a pharmacologically active agent. The combined one or more resins are present in a suitable amount such that the composition, when the solvent evaporates, will dry to form a solid coating that sticks to the skin, nail or mucosal membrane to which the composition is applied, and maintain the pharmacologically active agent over a sustained period of time in contact with sites on the skin or mucosal membranes exhibiting symptoms of the disease. Methods are provided for treating symptoms of dermatological diseases with such a pharmacological composition.
    Type: Grant
    Filed: July 30, 2008
    Date of Patent: April 29, 2014
    Assignee: Jaleva Pharmaceuticals, LLC
    Inventor: Alex Battaglia